Biomining Market

A stirred bio-oxidation tank heats itself: microbes oxidising pyrite and arsenopyrite release enough energy that Metso’s BIOX process keeps running through Kazakh winters below -40°C without external heating. The Biomining Market covers the microbial leaching, bio-oxidation, bioremediation and biosorption circuits that recover copper, gold, nickel, cobalt, uranium and zinc, plus the inoculants, bioreactors, licences and operating services behind them. Douglas Insights sizes it at USD 2.35 billion in 2025, from 4,600 thousand tonnes (kt) of bioleached copper multiplied by USD 511.9 of biological-circuit spend per tonne, and projects USD 4.05 billion by 2035, a revenue CAGR of 5.57%. Rio Tinto announced on 4 December 2025 that its Nuton bioleaching technology produced first copper cathode at the Johnson Camp mine in Arizona, 18 months after concept. Readers comparing adjacent spend can open the mining equipment and services hub, and every figure below can be rebuilt from our research methodology.

Why are primary sulphide heaps and leach-recovery projects behind biomining demand?

Bioleached copper tonnage grows 3.4% a year in the base case, lifting biomining spend from USD 2.35 billion. Four drivers explain the whole volume leg: primary sulphide heap leaching adds 1.35 points, stockpile leach recovery 1.20, refractory gold bio-oxidation 0.50 and nickel, cobalt and tailings circuits 0.35.

Primary sulphide heap bioleaching is the largest driver at 1.35 points. Rio Tinto reports that Nuton recovers up to 85% of copper from primary sulphides and removes concentration, smelting and refining, so 99.99% pure cathode leaves the mine gate. The Johnson Camp deployment targets about 30,000 tonnes of refined copper over a four-year demonstration, roughly 14 kt from Nuton and 16 kt from the run-of-mine pad. Rio Tinto puts the site footprint at 0.82 kg of CO2-e per kg of copper against a projected 2026 global average of 3.4 kg, and water use at 71 litres per kg against about 130 litres. Buyers of Low Carbon Copper Market volumes pay attention to exactly those two ratios.

Leach recovery at existing copper operations adds 1.20 points. Freeport-McMoRan reported on 22 January 2026 that its leach initiatives produced 214 million pounds of copper in 2025, reached a run rate near 240 million pounds late in the year and target 300 million pounds in 2026 (fourth-quarter 2025 results, Form 8-K exhibit). BHP says its own Full SaL leaching technology at Escondida delivered first production in the 2025 financial year and should yield about 410 kt of cathode over ten years. BHP does not call Full SaL bioleaching, so Douglas Insights counts it as leach-circuit tonnage that shares heap infrastructure with biomining rather than as a microbial process.

Refractory gold adds 0.50 points. Metso counts 13 commercial BIOX plants, more than 22 million ounces of gold produced and plant sizes from 20 to 2,137 tonnes of flotation concentrate a day. Endeavour Mining’s Sabodala-Massawa BIOX circuit in Senegal, built for 1.2 million tonnes of ore a year, is the newest large addition and showed above 72% metallurgical recovery in its first months.

Nickel, cobalt and tailings circuits supply the last 0.35 points. Europe’s 2030 benchmarks of 10% domestic extraction, 40% processing and 25% recycling for strategic raw materials reward recovery from low-grade and waste streams, the niche where biomining competes with reagent-heavy routes covered in the Mining Chemicals Market. Summed, 1.35 + 1.20 + 0.50 + 0.35 = 3.40 points, the full volume leg.

Which chalcopyrite and heap-temperature bottlenecks slow the biomining build-out?

Three bottlenecks pull the volume leg from 3.4% to 2.2% a year in the slower case, which with a 1.6% price leg leaves 2035 biomining spend at USD 3.43 billion. Chalcopyrite recovery removes 0.50 points, heap heat loss 0.40 and arsenic and permitting delays 0.30.

Chalcopyrite is the hardest ceiling. Over 70% of remaining copper resources sit in chalcopyrite, which typically yields only 20% to 25% in conventional heap bioleaching, against average recoveries above 80% for chalcocite and covellite on ores averaging 0.5% copper. Until primary sulphide heaps repeat Nuton’s 85% claim at several sites, 0.50 points of biomining volume stay at risk.

Heat is the second. A column study on low-grade chalcocite tested 20, 30, 45 and 60°C and found much higher copper recovery in the hotter column, even though microbial abundance peaked at 30°C; moderate thermophiles took over as temperature rose. A heap that loses heat to wind, rain or altitude falls back to slow mesophile leaching, so we remove 0.40 points for biomining pads in cold or wet climates.

Permitting is the third. BacTech’s Ecuador bioleach plant was 95% permitted and 90% engineered at the end of 2025, yet the company booked no Ecuador project spending that year. Small arsenic-bearing projects wait on finance as much as on microbes, and that drag removes 0.30 points.

Which metal makes the money in biomining: bioleached copper, refractory gold or nickel?

Copper makes the money: bioleached copper carries 71.4% of 2025 biomining spend, USD 1.68 billion, because heap and dump bioleaching treats by far the largest tonnage. Gold follows at 17.3%, nickel and cobalt at 6.2%, and uranium and zinc at 5.1% of the USD 2.35 billion total.

Copper, at USD 1.68 billion, leads because bioleaching already produces about 20% of world copper and every new primary sulphide heap adds tonnage at the same per-tonne spend. Gold, worth USD 407.4 million, rests on stirred-tank bio-oxidation of refractory concentrates, where 13 BIOX plants set the installed base. Nickel and cobalt, at USD 146.0 million, is the fastest-growing biomining segment at 7.10% a year because battery-metal buyers want low-carbon units from low-grade sulphides and tailings. Uranium and zinc, at USD 120.1 million, grows slowest at 3.05% since few new biological circuits are planned for either metal.

Douglas Insights expects copper’s share to edge up to about 74% by 2035 as Nuton-type pads come on stream, while gold’s slips toward 15%.

Where do Chilean bioleach pads and African BIOX tanks put biomining spend, by region?

Latin America leads with USD 1.10 billion, 46.8% of 2025 biomining spend, because Chile mined 5,510 kt of copper and Peru 2,740 kt in 2024. North America grows fastest at 6.41% a year, and Europe is the wildcard at USD 124.9 million.

Latin America reaches USD 1.85 billion by 2035, carried by Chilean heaps at Escondida and Spence that together run close to 200 kt a year of bioleached copper. North America climbs from USD 445.0 million to USD 828.3 million, the fastest biomining rate, because Arizona hosts both Nuton at Johnson Camp and much of Freeport-McMoRan’s leach programme, and the USGS counts 14 electrowon refineries in the United States, which mined 1,050 kt of copper in 2024. Asia Pacific holds USD 461.5 million on Chinese and Australian heap and tank circuits, with China mining 1,840 kt in 2024. The Middle East and Africa carries USD 221.3 million, led by BIOX gold in West Africa and copper leaching in the Democratic Republic of the Congo, which mined 2,990 kt in 2024. Europe’s USD 124.9 million is the wildcard: if strategic project status under the critical raw materials framework funds Nordic nickel and tailings bioleaching, its 4.31% rate is the figure most likely to be revised.

Which mining companies and technology licensors run the biggest biomining circuits?

Douglas Insights estimates BHP, Freeport-McMoRan and Metso together hold about 38.7% of 2025 biomining spend, a top-three concentration built from disclosed leach tonnage, BIOX plant counts and our per-tonne spend. BHP leads with a 17.9% share; no company publishes a biomining share itself.

BHP’s 17.9% rests on the largest bioleach tonnage in Chile. Freeport-McMoRan follows at 12.6%, since its 214 million pounds equals about 97.1 kt, or 2.1% of global bioleached copper. Metso’s 8.2% comes from licensing and supplying the stirred tanks behind most refractory gold bio-oxidation. Rio Tinto is the technology wildcard: Nuton is small in tonnes today but is the only primary sulphide biomining route with a commercial cathode and a licensing model aimed at third-party mines. Endeavour Mining and Gunnison Copper are buyers that prove the technology on their own ore, and BacTech shows how a small licensor builds a position around arsenic stabilisation.

How much does the biological stage of a copper heap leach cost per tonne?

Biological-circuit spend averages USD 511.9 per tonne of bioleached copper in 2025. Copper heaps account for USD 432.0, 9.6% of a USD 4,000 to 5,000 whole-route cost, plus an 18.5% uplift for gold, nickel and other biomining circuits. Price per tonne rises 2.1% a year.

The whole bioleach and solvent extraction and electrowinning (SX-EW) route costs about USD 4,000 to 5,000 per tonne of copper, roughly half of an integrated mine-smelter route, which is why biomining wins low-grade ore. At 9.6%, the biological stage of that cost runs from USD 384 to USD 480 per tonne. In refractory gold, BacTech’s feasibility study puts bioleach operating cost at USD 212 per tonne treated. Against metal value the bill is small: copper averaged 440 US cents per pound on the London Metal Exchange and 480 cents on COMEX in 2025, and Freeport-McMoRan realised USD 4.75 per pound. At 440 cents, or about USD 9,700 per tonne, biomining spend of USD 432.0 per tonne is 4.45% of the metal’s value. Douglas Insights puts the 2035 price at USD 630.1 per tonne as hotter, aerated and inoculated heaps replace passive dumps.

Which biomining offering do mine operators buy: inoculants, bioreactors or operating services?

Operating services take 46.3% of 2025 biomining spend, about USD 1.09 billion, because heaps need years of irrigation, aeration and solution control. Bioreactors and aeration equipment take 27.4%, licensing and engineering services 15.2%, and inoculants and microbial cultures 11.1% of the USD 2.35 billion.

Operating services, worth about USD 1.09 billion, cover heap irrigation, temperature and pH control and tank operation for the life of the pad. Bioreactors and aeration equipment, at USD 645.2 million, include the stirred tanks behind BIOX circuits sized from 20 to 2,137 tonnes of concentrate a day and the reactors where Nuton grows microbes at scale. Licensing and engineering services, at USD 357.9 million, are where Metso, Rio Tinto and BacTech earn on intellectual property rather than tonnes. Inoculants and microbial cultures, at USD 261.4 million, are the smallest line but the one most tied to recovery: a heap seeded with the right thermophiles is the difference between 25% and 85% copper recovery on sulphide ore.

Can bioremediation and biosorption turn tailings and arsenic concentrates into biomining revenue?

Douglas Insights puts bioremediation and biosorption at about 4.6% of 2025 biomining spend, USD 108.3 million, spread across tailings, acid drainage and arsenic stabilisation. The figure is small because few biological circuits on waste recover saleable metal; most of that spend is compliance.

Arsenic is the clearest case. BacTech’s BACOX process ends with ferric arsenate, which it describes as a land-fillable form of arsenic approved by the US Environmental Protection Agency, and its Ecuador feasibility study at USD 1,600 per ounce of gold shows 30,900 ounces a year, a USD 17.0 million capital cost and a 57.9% pre-tax internal rate of return. Its Ponce Enriquez district is expected to supply 200 to 250 tonnes a day of gold and arsenic concentrates. Recovery from waste streams overlaps with the Metal Recycling Market, and biosorption of metals from effluent is the bridge between the two.

How fast do biomining projects move from feasibility to first cathode or gold pour?

Nuton moved from concept to cathode in 18 months, against about 18 years for a typical copper mine, and that gap is the main commercial argument for biomining. Gold bio-oxidation circuits take two to three years from construction start to commercial output.

Rio Tinto made the 18-month comparison in its Johnson Camp release, and the next phase is multi-year testing with independent third-party verification. Endeavour started building its Sabodala-Massawa BIOX expansion in 2022 and reached commercial production in 2024. BacTech shows the slow end: its 2025 annual MD and A dates the bankable feasibility summary to 16 December 2021, the environmental and social impact assessment (ESIA) approval to 3 October 2022 and a consultation permit to November 2023, and the plant is still unbuilt. Douglas Insights counts that spread, 18 months to more than four years, as the main source of timing risk in the biomining forecast.

What if Nuton-style sulphide heaps scale faster: which 2035 biomining case holds?

The base biomining case reaches USD 4.05 billion in 2035 on 3.4% volume and 2.1% price growth. The slower case lands at USD 3.43 billion on 2.2% and 1.6%, and the faster case at USD 4.73 billion on 4.6% and 2.5%.

The faster case assumes the cathode Rio Tinto announced on 4 December 2025 becomes a licensed template on three or four more primary sulphide heaps before 2030, and that Freeport-McMoRan passes its 300 million pound target. Adding one point to bioleached tonnage growth, with price unchanged, raises 2035 spend by USD 409.1 million. Outside forecasts we reviewed span 3.5% to 14.2% a year; our 5.57% sits in the lower third because we count biological-circuit spend, not the value of the metal recovered.

Which critical raw materials rules and arsenic policies govern biomining permits?

Regulation (EU) 2024/1252, the Critical Raw Materials Act (CRMA), entered into force on 23 May 2024 and lists 34 critical and 17 strategic raw materials, setting the policy frame for European biomining. Its 2030 benchmarks are 10% extraction, 40% processing and 25% recycling (European Parliament summary).

The CRMA also caps reliance on any single third country at 65% of annual consumption of a strategic raw material, which favours domestic biomining of low-grade nickel, cobalt and copper stockpiles over imported concentrate. In the Americas the binding rules are environmental permits and arsenic disposal: BacTech’s Ecuador ESIA shows a 2022 approval still waiting on finance in 2025. Rio Tinto’s water claim of up to 80% less than a concentrator, and 60% lower carbon, is the kind of figure permit reviewers now ask biomining applicants to verify.

Douglas Exclusive: the Bioleach Tonnage Ledger

The Bioleach Tonnage Ledger is a Douglas Insights model, not an official register, built from 11 sourced inputs. They are world mine output, the bioleach share, three Freeport-McMoRan leach figures, two BHP figures, two Nuton figures and two BIOX figures. It asks how much of the decade’s biomining tonnage growth is already tied to a named project.

The base case needs bioleached copper to rise from 4,600 kt in 2025 to about 6,426 kt in 2035, an increase of 1,826 kt a year by the end of the decade. Named projects account for 83.5 kt, only 4.6% of that gap. The finding is blunt: 95.4% of the biomining volume growth in this forecast still has to come from heaps, tanks and licences nobody has announced, which is why the slower case is not a tail risk. BIOX adds a gold line the ledger keeps separate: 13 plants and 22 million ounces show how slowly the tank route has spread across 30 years.

Which methodology checks hold the 4,600 kt bioleached copper receipt together?

Our arithmetic runs in two lines: 23,000 kt of 2025 world mine copper times a 20% bioleach share gives 4,600 kt. Then 4,600,000 tonnes times USD 511.9 gives USD 2.35 billion of biomining spend, checked four ways below.

Five regions and four metal segments are modelled separately and reconcile to the global figure in 2025 and 2035; segment 2035 values sum within 0.6% of USD 4.05 billion. Four cross-checks hold. The USD 432.0 copper stage equals 9.6% of a USD 4,500 midpoint route cost. Spend per tonne equals 4.45% of the 2025 London Metal Exchange copper price. Freeport-McMoRan’s 97.1 kt equals 2.1% of the 4,600 kt base, consistent with its 12.6% spend share once licensing and gold are added elsewhere. Four outside CAGRs, 3.5% to 14.2%, bracket our 5.57%. Douglas Insights counts 11 ledger inputs, 7 primary-source documents and 2 technical references in the model.

Sources

1. Rio Tinto Rio Tinto's Nuton technology produces first copper (2025)
2. Freeport-McMoRan (SEC) Fourth-quarter and year 2025 results, Form 8-K exhibit 99.1 (2026)
3. US Geological Survey Mineral Commodity Summaries 2026: Copper (2026)
4. Metso BIOX process (2025)
5. European Parliament Legislative Observatory Regulation (EU) 2024/1252 document summary (2024)
6. BacTech Environmental (CSE filing) BacTech MD and A, year ended 31 December 2025 (2026)
7. BHP (SEC) BHP Form 6-K, 2025 financial year results (2025)